| Prev Close | 422.29 |
| Open | 426.51 |
| Day Low/High | 424.04 / 431.12 |
| 52 Wk Low/High | 250.21 / 441.96 |
| Volume | 1.10M |
Thermo Fisher Scientific Inc. (TMO)
428.68
6.40
1.50
NYSE
| Exchange | NYSE |
| Shares Outstanding | 395.59B |
| Market Cap | 165.41B |
| P/E Ratio | 45.25 |
| Div & Yield | N.A. (N.A) |
Jim Cramer: All These Stocks Are Not Quite 'Dow and Out'
Let's look at the Dow Jones' swapping of Exxon for Salesforce, Pfizer for Amgen and Raytheon for Honeywell.
PerkinElmer Could Rally Further After a Big Consolidation Breakout
The charts of the life sciences company suggest its stock could make a large upside move.
Markets at a Crossroads, Trump on Health Crisis, China to Shut Houston Consulate
The markets are really in the hands of Washington right now, and Washington is in the hands of the virus.
Jim Cramer: 20 Stocks That Are Emblematic of What's Driving the Market
This list is not a buy list but a list of stocks that have been brought to new heights.
Mid-Caps Outperform, Funding 'Paycheck Protection', U.K. Vaccine Trials
Trading volumes dropping on major indexes, U.K. teams begin human trials on a Covid-19 vaccine, and the U.S. Senate wants another stimulus package addition.
I'm Dusting Off My Old Playbook for Bonds Right Now
After a strong day for fixed-income markets, let's learn from 2008 how to play this volatility.
Thermo Fisher Scientific's Covid-19 Test Could Help It Test Higher Ground
The pace of the selloff in shares of the maker of lab equipment has begun to slow and that is a positive.
Healthy Upside Potential In Medical Devices and Services Stocks
Some of the best opportunities are in lesser-known niche markets such as medical devices and services.
The Fed's Moves, Trading 5 Stocks, Coronavirus and the Market: Market Recon
It's no secret that the Fed would like to get out of the short-term repo business.
Thermo Fisher Scientific Could Trade Higher in the Weeks and Months Ahead
The charts of TMO are positive.
Trading ServiceNow, Defense Cloud Contract, Flat Netflix Stock: Market Recon
The Defense Department's potential $10 billion award for their cloud computing contract is a never ending saga with Microsoft and Amazon as finalists.
Real Money Post-Industrial Average Leads Major Indexes So Far for Year
In July, the RMPIA climbed 0.6%, bringing its year-to-date return to just over 21%.
Feds Probe Tech, Mueller Speaks, Holy Guacamole and Now Hear NOW: Market Recon
Watch closely as the government opens a broad antitrust investigation into unidentified leading online technology platforms
Selected Earnings
United Parcel Service EPS: beat Revs: beat, +3.4% y/y Record profit across all segments Raised guidance  AT&T EPS: in line Revs: in line, +15.3% y/y Subscriber losses Raised guidance for free cash flow  General Dynamics EPS: beat Revs: beat, +4.0%...
Danaher Could Dip Near-Term, Providing a Buying Opportunity
DHR shares are up 35% in 2019.
Thermo Fisher Scientific Is Showing Us 3 Strong Charts
Here's how to play the stock right now.
Netflix Taking a Knife to a Gunfight with Disney, Apple, Plus Bitcoin
Bitcoin, the most famous of all crypto-currencies, has enjoyed something of a rebound of late.
Keep Your Eye on the Oncology Sector Among Biotech Stocks
The myriad names in oncology have been the hottest area for acquisitions along with gene therapy.
Why Huawei Matters, FOMC Decision, AAPL Results, Watching NOW: Market Recon
I think we can all agree that there will be no increase made to the Fed Funds Rate today.
Thermo Fisher Shows Super Relative Strength - Go Long or Add to Longs
Let's check the charts and indicators.
How to Trade Microsoft Into Earnings: Market Recon
Add to longs near this key support level.
Jim Cramer: Valuations Now Have No Relation to Common Sense
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
How to Play a Possible Breakout in Starbucks: Market Recon
This options strategy on SBUX offers potential reward with little risk.
Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back
The crash of oil will only accelerate the move.
Jim Cramer: Follow the Bouncing Equities
Markets start day with a bungee jump.
Uncertainty Is the New Market Normal -- And More Severe Tests Are Coming
There is likely more headline risk to our front than to our rear.
Big Pharma and the Sellers of Its Products Now Have a Problem
Who, out there in the health care sector, is safe?
